Philips Healthcare US to include SyntheticMR’s solution in product catalogue
SyntheticMR announced today that they have signed an agreement with Philips Healthcare US that involves integrating SyntheticMR’s imaging software solution SyMRI into the Philips product catalogue. The Philips Healthcare US sales team will now be able to offer SyntheticMR’s full solution to their customers.
“Healthcare providers in North America through this collaboration will now have quicker access to a solution that can help shorten scan times, improve patient throughput and provide quantitative data, which will be critical in post COVID-19 times,” says Kyle Frye, President SyntheticMR Inc. “I am excited to accelerate our growth on the US market together with Philips Healthcare and for their sales team to begin selling our product by mid-June.”
Philips Healthcare currently offers the quantitative sequence SyntAc as an option to their customers, and adding SyntheticMR’s software solution enables the customer to generate multiple contrast-weighted images and volumetric data in a single 5-6 minute scan. SyntheticMR’s product is compatible with most MRI scanners from Philips Healthcare.
“Philips Healthcare is an important partner in our ambitions to provide customers with workflow improvements and objective decision support,” says Ulrik Harrysson, CEO, SyntheticMR AB. “This agreement is an important step for a closer collaboration with Philips Healthcare on a global level.”
For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com or Kyle Frye, President SyntheticMR Inc. at +1 (859) 512 - 9496 or kyle.frye@syntheticmr.com.
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB’s product SyMRI® delivers multiple contrast images and quantitative data from a single 6-minute scan. The product is available in different packages. SyMRI IMAGE supports faster MRI workflows and improved patient throughput. SyMRI NEURO delivers automatic segmentation of brain tissue, supporting objective decision support. SyMRI is CE-marked and FDA 510(k) cleared. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the Spotlight Stock Market in Stockholm, Sweden. For additional information, please visit www.syntheticmr.com.
This information is information that SyntheticMR AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on May 18 2020.